Skip to main content
market.news — Markets without borders

market.news daily briefing

Australia Daily Briefing

Friday, 31 July 2026

📉 ASX 200 breaks above 9000 points but iShares MSCI Australia sheds -1.6% as CSL -2.7% and mining -1.4% dominate

Australia's iShares MSCI Australia declined 1.61% — one of the sharper sessions of recent weeks — as healthcare led lower with CSL falling 2.69% and mining dropped 1.37%. The divergence from the index-level read is notable: smallcaps.com.au reports the ASX 200 itself moved above the 9000-point barrier (a milestone), but the iShares ETF's composition-weighted performance reflects the dominance of its large-cap healthcare and mining weights over the broader index's more mixed performance. Macquarie (MQBKY +0.74%) was the session's lone meaningful gainer among tracked names. NEM (Newmont) fell 2.14%, BHP declined, confirming the mining sector weakness is broad-based across both base metals and gold. RBA policy trajectory and the AUD/USD basis remain the Australian investor's primary macro variables, alongside the China demand signal that drives the ASX 200's disproportionate mining-sector exposure.

By the numbers

iShares MSCI AustraliaEWA
29.34
-1.61%(-0.48)

3 things that moved markets

1.

ASX 200 Crosses 9000 Points on Positive Copper Outlook

The ASX 200 moved above the 9000-point barrier, per smallcaps.com.au, on positive copper price sentiment — a milestone that reflects the Australian market's commodity-driven recovery from earlier-year lows. The copper-driven narrative aligns with Surge Copper's 8% NI 43-101 filing gain this week, suggesting the market is beginning to price in supply-side development progress in copper, a metal where Australian and Canadian miners have significant exploration pipelines. The 9000 level has psychological significance as a resistance-turned-support for future AUD-hedged positions.

Read at smallcaps.com.au
2.

Monadelphous Group Wins $165M Rio Tinto Design-and-Construct Contract

Monadelphous Group's Kerman division secured a $165 million design-and-construction contract from Rio Tinto, The Market Herald reports — a significant engineering services win that confirms Rio Tinto's continued capital investment in Australian mining infrastructure. For ASX engineering and construction investors, a $165M single-contract win from Rio Tinto validates the thesis that major miners are maintaining capex despite commodity price volatility. Monadelphous is the clearest local beneficiary of Rio's sustained WA iron ore and aluminium expansion.

Read at The Market Herald
3.

Cobalt Blue Holdings Advances Kwinana Refinery Toward Final Investment Decision

Cobalt Blue Holdings is progressing its Kwinana cobalt sulfate refinery toward a Final Investment Decision (FID), per smallcaps.com.au — a milestone that would position the company as a domestic Australian cobalt processor supplying EV battery supply chains without export. For ASX battery-metals investors, an FID at Kwinana would be a critical derisking event in a sector where development-stage companies have faced extended capital markets challenges. The timing alongside global AI infrastructure-driven power demand (which requires battery storage) adds thematic support.

Read at smallcaps.com.au

Top movers

Gainers (1)

MQBKYMQBKY+0.74%

Losers (4)

CSLCSL-2.69%NEMNEM-2.14%BHPBHP-1.64%RIORIO-0.34%

Sector heatmap

Mining-1.37%Banks+0.74%Healthcare-2.69%

Smart-money note

Mining's -1.37% session performance against a positive copper sentiment backdrop (ASX 200 crossed 9000 on copper news) creates a paradox worth unpacking: the large-cap miners (BHP, NEM/Newmont) appear to be de-rating while smaller copper-exposed names benefit from the favorable commodity signal. This divergence suggests institutional holders of large-cap mining positions are rotating toward more specific copper/lithium-adjacent plays rather than the diversified miners. CSL's -2.69% is the more interesting question — Australia's largest biotech/healthcare name rarely moves this significantly without a company-specific catalyst. Check for any CMS or regulatory communication about CSL's Seqirus flu vaccine manufacturing or Behring plasma franchise. Macquarie's +0.74% outperformance confirms the premium on financial infrastructure and alternatives management over commodity exposure in the current institutional playbook. RBA's next rate decision is the AUD/USD variable that determines whether Australian superannuation flows into domestic equities or rebalance toward international exposure — a stable AUD supports domestic equity retention. Risk for tomorrow: if China PMI data disappoints on the manufacturing side, ASX mining exposure faces another down session regardless of commodity spot prices.

What to watch tomorrow

CSL -2.7% catalyst needed

CSL's decline on no obvious macro catalyst suggests a company-specific event. Check for TGA regulatory action, seasonal flu vaccine volumes, or plasma collection data — any of these could explain the move and determine whether today's decline is a buying opportunity or an earnings preview signal.

China PMI and iron ore

BHP and NEM's declines against a positive copper-sentiment headline show that large-cap mining investors are already pricing in China demand caution. Official China PMI data and iron ore spot price are the direct indicators for whether the ASX materials sector finds support or extends its slide.

RBA rate communication

The AUD/USD basis directly affects the relative attractiveness of Australian equities to global portfolios. Any RBA communication about the cash rate trajectory ahead of the next meeting determines whether superannuation flows rotate toward international assets (AUD weakens → foreign assets worth more in AUD) or stay domestic.

Browse all Australia briefings →